PAI-1 had been regarded as a mesenchymal marker and thoroughly confirmed to be a pivotal downstream effector on EMT induced by TGF-β in various cancer, such as lung cancer, gastric cancer and colorectal carcinoma cells [41–44]. The gene discussed is TGFB1; the disease is colorectal carcinoma.